{"transactions":[{"id":884453,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":64915,"kind":"person","name":"Adcock Richard","position":1,"cik":"0001830328","reported_name":"Adcock Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Restricted Stock Units","published_at":"2026-02-25T01:04:54.000Z","date":"2026-02-22","kind":"exercise","planned":false,"acquired":false,"shares":152439,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ImmunityBio, Inc. (the \"Issuer\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the Issuer's Amended and Restated 2015 Equity Incentive Plan) through each applicable vesting date, 33.33% of the shares subject to the RSU award shall vest in equal annual installments on each of the first and second anniversaries of the vesting commencement date and 33.34% of the shares subject to the RSU award shall vest on the third anniversary of the vesting commencement date, such that all shares shall be fully vested on the third anniversary of the vesting commencement date. The vesting commencement date for this RSU award is February 22, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the Issuer's Amended and Restated 2015 Equity Incentive Plan) through each applicable vesting date, 33.33% of the shares subject to the RSU award shall vest in equal annual installments on each of the first and second anniversaries of the vesting commencement date and 33.34% of the shares subject to the RSU award shall vest on the third anniversary of the vesting commencement date, such that all shares shall be fully vested on the third anniversary of the vesting commencement date. The vesting commencement date for this RSU award is February 22, 2024."}],"balance_after":152439,"derivative":{"underlying":"Common Stock","underlying_shares":152439},"source":{"system":"sec-edgar","filing":"0001830328-26-000005","document":"wk-form4_1771981491.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000183032826000005/wk-form4_1771981491.xml","form_type":"4"}},{"id":884452,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":64915,"kind":"person","name":"Adcock Richard","position":1,"cik":"0001830328","reported_name":"Adcock Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2026-02-25T01:04:54.000Z","date":"2026-02-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":77560,"price":8.7,"value":674772.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 22, 2026, the Reporting Person's RSUs vested. The closing price of Immunity Bio, Inc.'s common stock on February 20, 2026 was the settlement price used to calculate the shares withheld."}],"balance_after":560344,"source":{"system":"sec-edgar","filing":"0001830328-26-000005","document":"wk-form4_1771981491.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000183032826000005/wk-form4_1771981491.xml","form_type":"4"}},{"id":884451,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":64915,"kind":"person","name":"Adcock Richard","position":1,"cik":"0001830328","reported_name":"Adcock Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2026-02-25T01:04:54.000Z","date":"2026-02-22","kind":"exercise","planned":false,"acquired":true,"shares":152439,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ImmunityBio, Inc. (the \"Issuer\") common stock."}],"balance_after":637904,"source":{"system":"sec-edgar","filing":"0001830328-26-000005","document":"wk-form4_1771981491.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000183032826000005/wk-form4_1771981491.xml","form_type":"4"}},{"id":907420,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":64915,"kind":"person","name":"Adcock Richard","position":1,"cik":"0001830328","reported_name":"Adcock Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Restricted Stock Units","published_at":"2026-02-13T01:50:26.000Z","date":"2026-02-10","kind":"exercise","planned":false,"acquired":false,"shares":274122,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ImmunityBio, Inc. (the \"Issuer\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the Issuer's Amended and Restated 2015 Equity Incentive Plan) through each applicable vesting date, 33.33% of the shares subject to the RSU award shall vest in equal annual installments on each of the first and second anniversaries of the vesting commencement date and 33.34% of the shares subject to the RSU award shall vest on the third anniversary of the vesting commencement date, such that all shares shall be fully vested on the third anniversary of the vesting commencement date. The vesting commencement date for this RSU award is February 10, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the Issuer's Amended and Restated 2015 Equity Incentive Plan) through each applicable vesting date, 33.33% of the shares subject to the RSU award shall vest in equal annual installments on each of the first and second anniversaries of the vesting commencement date and 33.34% of the shares subject to the RSU award shall vest on the third anniversary of the vesting commencement date, such that all shares shall be fully vested on the third anniversary of the vesting commencement date. The vesting commencement date for this RSU award is February 10, 2025."}],"balance_after":548246,"derivative":{"underlying":"Common Stock","underlying_shares":274122},"source":{"system":"sec-edgar","filing":"0001830328-26-000003","document":"wk-form4_1770947424.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000183032826000003/wk-form4_1770947424.xml","form_type":"4"}},{"id":907419,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":64915,"kind":"person","name":"Adcock Richard","position":1,"cik":"0001830328","reported_name":"Adcock Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2026-02-13T01:50:26.000Z","date":"2026-02-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":140048,"price":6.93,"value":970532.64,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 10, 2026, the reporting person's RSUs vested. The closing price of the Issuer's common stock on February 9, 2026 was the settlement price used to calculate the shares withheld."}],"balance_after":485465,"source":{"system":"sec-edgar","filing":"0001830328-26-000003","document":"wk-form4_1770947424.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000183032826000003/wk-form4_1770947424.xml","form_type":"4"}},{"id":907418,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":64915,"kind":"person","name":"Adcock Richard","position":1,"cik":"0001830328","reported_name":"Adcock Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2026-02-13T01:50:26.000Z","date":"2026-02-10","kind":"exercise","planned":false,"acquired":true,"shares":274122,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ImmunityBio, Inc. (the \"Issuer\") common stock."}],"balance_after":625513,"source":{"system":"sec-edgar","filing":"0001830328-26-000003","document":"wk-form4_1770947424.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000183032826000003/wk-form4_1770947424.xml","form_type":"4"}},{"id":950825,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":64915,"kind":"person","name":"Adcock Richard","position":1,"cik":"0001830328","reported_name":"Adcock Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Restricted Stock Units","published_at":"2026-01-05T23:10:33.000Z","date":"2025-12-31","kind":"exercise","planned":false,"acquired":false,"shares":34483,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ImmunityBio, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Five percent (5%) of the 172,420 RSUs (rounded down to the nearest whole share) vested on September 9, 2021; five percent (5%) of the RSUs (rounded down to the nearest whole share) vested on December 31, 2022; twenty percent (20%) of the RSUs (rounded down to the nearest whole share) vested on December 31, 2023; twenty percent (20%) of the RSUs (rounded down to the nearest whole share) vested on December 31, 2024; twenty percent (20%) of the RSUs (rounded down to the nearest whole share) vested on December 31, 2025; and the remaining RSUs will vest on December 31, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Five percent (5%) of the 172,420 RSUs (rounded down to the nearest whole share) vested on September 9, 2021; five percent (5%) of the RSUs (rounded down to the nearest whole share) vested on December 31, 2022; twenty percent (20%) of the RSUs (rounded down to the nearest whole share) vested on December 31, 2023; twenty percent (20%) of the RSUs (rounded down to the nearest whole share) vested on December 31, 2024; twenty percent (20%) of the RSUs (rounded down to the nearest whole share) vested on December 31, 2025; and the remaining RSUs will vest on December 31, 2026."}],"balance_after":51731,"derivative":{"underlying":"Common Stock","underlying_shares":34483},"source":{"system":"sec-edgar","filing":"0001830328-26-000001","document":"wk-form4_1767654629.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000183032826000001/wk-form4_1767654629.xml","form_type":"4"}},{"id":950824,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":64915,"kind":"person","name":"Adcock Richard","position":1,"cik":"0001830328","reported_name":"Adcock Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2026-01-05T23:10:33.000Z","date":"2025-12-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":17510,"price":1.98,"value":34669.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On December 31, 2025, the Reporting Person's RSUs vested. The closing price of Immunity Bio, Inc.'s common stock on December 30, 2025 was the settlement price used to calculate the shares withheld."}],"balance_after":351391,"source":{"system":"sec-edgar","filing":"0001830328-26-000001","document":"wk-form4_1767654629.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000183032826000001/wk-form4_1767654629.xml","form_type":"4"}},{"id":950823,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":64915,"kind":"person","name":"Adcock Richard","position":1,"cik":"0001830328","reported_name":"Adcock Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2026-01-05T23:10:33.000Z","date":"2025-12-31","kind":"exercise","planned":false,"acquired":true,"shares":34483,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ImmunityBio, Inc. common stock."}],"balance_after":368901,"source":{"system":"sec-edgar","filing":"0001830328-26-000001","document":"wk-form4_1767654629.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000183032826000001/wk-form4_1767654629.xml","form_type":"4"}},{"id":1245766,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":64915,"kind":"person","name":"Adcock Richard","position":1,"cik":"0001830328","reported_name":"Adcock Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Restricted Stock Units","published_at":"2025-02-26T02:11:15.000Z","date":"2025-02-22","kind":"exercise","planned":false,"acquired":false,"shares":152439,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ImmunityBio, Inc. (the \"Issuer\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the Issuer's Amended and Restated 2015 Equity Incentive Plan) through each applicable vesting date, 33.33% of the shares subject to the RSU award shall vest in equal annual installments on each of the first and second anniversaries of the vesting commencement date and 33.34% of the shares subject to the RSU award shall vest on the third anniversary of the vesting commencement date, such that all shares shall be fully vested on the third anniversary of the vesting commencement date. The vesting commencement date for this RSU award is February 22, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the Issuer's Amended and Restated 2015 Equity Incentive Plan) through each applicable vesting date, 33.33% of the shares subject to the RSU award shall vest in equal annual installments on each of the first and second anniversaries of the vesting commencement date and 33.34% of the shares subject to the RSU award shall vest on the third anniversary of the vesting commencement date, such that all shares shall be fully vested on the third anniversary of the vesting commencement date. The vesting commencement date for this RSU award is February 22, 2024."}],"balance_after":304878,"derivative":{"underlying":"Common Stock","underlying_shares":152439},"source":{"system":"sec-edgar","filing":"0001326110-25-000021","document":"wk-form4_1740535870.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000021/wk-form4_1740535870.xml","form_type":"4"}},{"id":1245765,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":64915,"kind":"person","name":"Adcock Richard","position":1,"cik":"0001830328","reported_name":"Adcock Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2025-02-26T02:11:15.000Z","date":"2025-02-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":78167,"price":3.42,"value":267331.14,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 22, 2025, the Reporting Person's RSUs vested. The closing price of Immunity Bio, Inc.'s common stock on February 21, 2025 was the settlement price used to calculate the shares withheld."}],"balance_after":334418,"source":{"system":"sec-edgar","filing":"0001326110-25-000021","document":"wk-form4_1740535870.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000021/wk-form4_1740535870.xml","form_type":"4"}},{"id":1245764,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":64915,"kind":"person","name":"Adcock Richard","position":1,"cik":"0001830328","reported_name":"Adcock Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2025-02-26T02:11:15.000Z","date":"2025-02-22","kind":"exercise","planned":false,"acquired":true,"shares":152439,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ImmunityBio, Inc. (the \"Issuer\") common stock."}],"balance_after":412585,"source":{"system":"sec-edgar","filing":"0001326110-25-000021","document":"wk-form4_1740535870.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000021/wk-form4_1740535870.xml","form_type":"4"}},{"id":1271414,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":64915,"kind":"person","name":"Adcock Richard","position":1,"cik":"0001830328","reported_name":"Adcock Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Stock Option (right to buy)","published_at":"2025-02-13T01:16:36.000Z","date":"2025-02-10","kind":"grant","planned":false,"acquired":true,"shares":2812500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the Issuer's Amended and Restated 2015 Equity Incentive Plan) through each applicable vesting date, 33.33% of the shares subject to the option shall vest in equal annual installments on each of the first and second anniversaries of the vesting commencement date and 33.34% of the shares subject to the option shall vest on the third anniversary of the vesting commencement date, such that all shares shall be fully vested on the third anniversary of the vesting commencement date. The vesting commencement date for this option is February 10, 2025."}],"balance_after":2812500,"derivative":{"exercise_price":3.39,"expiration_date":"2035-02-10","underlying":"Common Stock","underlying_shares":2812500},"source":{"system":"sec-edgar","filing":"0001326110-25-000011","document":"wk-form4_1739409389.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000011/wk-form4_1739409389.xml","form_type":"4"}},{"id":1271413,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":64915,"kind":"person","name":"Adcock Richard","position":1,"cik":"0001830328","reported_name":"Adcock Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Restricted Stock Units","published_at":"2025-02-13T01:16:36.000Z","date":"2025-02-10","kind":"grant","planned":false,"acquired":true,"shares":822368,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ImmunityBio, Inc. (the \"Issuer\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the Issuer's Amended and Restated 2015 Equity Incentive Plan) through each applicable vesting date, 33.33% of the shares subject to the RSU award shall vest in equal annual installments on each of the first and second anniversaries of the vesting commencement date and 33.34% of the shares subject to the RSU award shall vest on the third anniversary of the vesting commencement date, such that all shares shall be fully vested on the third anniversary of the vesting commencement date. The vesting commencement date for this RSU award is February 10, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the Issuer's Amended and Restated 2015 Equity Incentive Plan) through each applicable vesting date, 33.33% of the shares subject to the RSU award shall vest in equal annual installments on each of the first and second anniversaries of the vesting commencement date and 33.34% of the shares subject to the RSU award shall vest on the third anniversary of the vesting commencement date, such that all shares shall be fully vested on the third anniversary of the vesting commencement date. The vesting commencement date for this RSU award is February 10, 2025."}],"balance_after":822368,"derivative":{"underlying":"Common Stock","underlying_shares":822368},"source":{"system":"sec-edgar","filing":"0001326110-25-000011","document":"wk-form4_1739409389.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000011/wk-form4_1739409389.xml","form_type":"4"}},{"id":1314202,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":64915,"kind":"person","name":"Adcock Richard","position":1,"cik":"0001830328","reported_name":"Adcock Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Restricted Stock Units","published_at":"2025-01-03T21:54:35.000Z","date":"2024-12-31","kind":"exercise","planned":false,"acquired":false,"shares":34483,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ImmunityBio, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Five percent (5%) of the 172,420 RSUs (rounded down to the nearest whole share) vested on September 9, 2021; five percent (5%) of the RSUs (rounded down to the nearest whole share) vested on December 31, 2022; twenty percent (20%) of the RSUs (rounded down to the nearest whole share) vested on December 31, 2023; twenty percent (20%) of the RSUs (rounded down to the nearest whole share) vested on December 31, 2024; twenty percent (20%) of the RSUs (rounded down to the nearest whole share) will vest on December 31, 2025; and the remaining RSUs will vest on December 31, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Five percent (5%) of the 172,420 RSUs (rounded down to the nearest whole share) vested on September 9, 2021; five percent (5%) of the RSUs (rounded down to the nearest whole share) vested on December 31, 2022; twenty percent (20%) of the RSUs (rounded down to the nearest whole share) vested on December 31, 2023; twenty percent (20%) of the RSUs (rounded down to the nearest whole share) vested on December 31, 2024; twenty percent (20%) of the RSUs (rounded down to the nearest whole share) will vest on December 31, 2025; and the remaining RSUs will vest on December 31, 2026."}],"balance_after":86214,"derivative":{"underlying":"Common Stock","underlying_shares":34483},"source":{"system":"sec-edgar","filing":"0001326110-25-000004","document":"wk-form4_1735941268.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000004/wk-form4_1735941268.xml","form_type":"4"}},{"id":1314201,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":64915,"kind":"person","name":"Adcock Richard","position":1,"cik":"0001830328","reported_name":"Adcock Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2025-01-03T21:54:35.000Z","date":"2024-12-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":17475,"price":2.56,"value":44736.0,"ownership":{"direct":true},"balance_after":260146,"source":{"system":"sec-edgar","filing":"0001326110-25-000004","document":"wk-form4_1735941268.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000004/wk-form4_1735941268.xml","form_type":"4"}},{"id":1314200,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":64915,"kind":"person","name":"Adcock Richard","position":1,"cik":"0001830328","reported_name":"Adcock Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2025-01-03T21:54:35.000Z","date":"2024-12-31","kind":"exercise","planned":false,"acquired":true,"shares":34483,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":277621,"source":{"system":"sec-edgar","filing":"0001326110-25-000004","document":"wk-form4_1735941268.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000004/wk-form4_1735941268.xml","form_type":"4"}},{"id":1619047,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":64915,"kind":"person","name":"Adcock Richard","position":1,"cik":"0001830328","reported_name":"Adcock Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Stock Option (right to buy)","published_at":"2024-02-26T21:38:41.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":1591463,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the Issuer's Amended and Restated 2015 Equity Incentive Plan) through each applicable vesting date, 33.33% of the shares subject to the option shall vest in equal annual installments on each of the first and second anniversaries of the vesting commencement date and 33.34% of the shares subject to the option shall vest on the third anniversary of the vesting commencement date, such that all shares shall be fully vested on the third anniversary of the vesting commencement date. The vesting commencement date for this option is February 22, 2024."}],"balance_after":1591463,"derivative":{"exercise_price":5.24,"expiration_date":"2034-02-22","underlying":"Common Stock","underlying_shares":1591463},"source":{"system":"sec-edgar","filing":"0001326110-24-000025","document":"wk-form4_1708983489.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611024000025/wk-form4_1708983489.xml","form_type":"4"}},{"id":1619046,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":64915,"kind":"person","name":"Adcock Richard","position":1,"cik":"0001830328","reported_name":"Adcock Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Restricted Stock Units","published_at":"2024-02-26T21:38:41.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":457317,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ImmunityBio, Inc. (the \"Issuer\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the Issuer's Amended and Restated 2015 Equity Incentive Plan) through each applicable vesting date, 33.33% of the shares subject to the RSU award shall vest in equal annual installments on each of the first and second anniversaries of the vesting commencement date and 33.34% of the shares subject to the RSU award shall vest on the third anniversary of the vesting commencement date, such that all shares shall be fully vested on the third anniversary of the vesting commencement date. The vesting commencement date for this RSU award is February 22, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the Issuer's Amended and Restated 2015 Equity Incentive Plan) through each applicable vesting date, 33.33% of the shares subject to the RSU award shall vest in equal annual installments on each of the first and second anniversaries of the vesting commencement date and 33.34% of the shares subject to the RSU award shall vest on the third anniversary of the vesting commencement date, such that all shares shall be fully vested on the third anniversary of the vesting commencement date. The vesting commencement date for this RSU award is February 22, 2024."}],"balance_after":457317,"derivative":{"underlying":"Common Stock","underlying_shares":457317},"source":{"system":"sec-edgar","filing":"0001326110-24-000025","document":"wk-form4_1708983489.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611024000025/wk-form4_1708983489.xml","form_type":"4"}},{"id":1656687,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":64915,"kind":"person","name":"Adcock Richard","position":1,"cik":"0001830328","reported_name":"Adcock Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Restricted Stock Units","published_at":"2024-02-07T02:14:34.000Z","date":"2024-02-05","kind":"exercise","planned":false,"acquired":false,"shares":83334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\")  represents a contingent right to receive one share of ImmunityBio, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the Amended and Restated 2015 Equity Incentive Plan) through each applicable vesting date, 83,333 of the shares subject to the RSU award vested in equal annual installments on each of the first and second anniversaries of the vesting commencement date and 83,334 of the shares vested on the third anniversary of the vesting commencement date, such that all shares were vested on the third anniversary of the vesting commencement date. The vesting commencement date for this RSU award was February 5, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the Amended and Restated 2015 Equity Incentive Plan) through each applicable vesting date, 83,333 of the shares subject to the RSU award vested in equal annual installments on each of the first and second anniversaries of the vesting commencement date and 83,334 of the shares vested on the third anniversary of the vesting commencement date, such that all shares were vested on the third anniversary of the vesting commencement date. The vesting commencement date for this RSU award was February 5, 2021."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":83334},"source":{"system":"sec-edgar","filing":"0001326110-24-000018","document":"wk-form4_1707272064.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611024000018/wk-form4_1707272064.xml","form_type":"4"}},{"id":1656686,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":64915,"kind":"person","name":"Adcock Richard","position":1,"cik":"0001830328","reported_name":"Adcock Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2024-02-07T02:14:34.000Z","date":"2024-02-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":43165,"price":4.04,"value":174386.6,"ownership":{"direct":true},"balance_after":243138,"source":{"system":"sec-edgar","filing":"0001326110-24-000018","document":"wk-form4_1707272064.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611024000018/wk-form4_1707272064.xml","form_type":"4"}},{"id":1656685,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":64915,"kind":"person","name":"Adcock Richard","position":1,"cik":"0001830328","reported_name":"Adcock Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2024-02-07T02:14:34.000Z","date":"2024-02-05","kind":"exercise","planned":false,"acquired":true,"shares":83334,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":286303,"source":{"system":"sec-edgar","filing":"0001326110-24-000018","document":"wk-form4_1707272064.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611024000018/wk-form4_1707272064.xml","form_type":"4"}},{"id":1691683,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":64915,"kind":"person","name":"Adcock Richard","position":1,"cik":"0001830328","reported_name":"Adcock Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Restricted Stock Units","published_at":"2024-01-04T02:40:45.000Z","date":"2023-12-31","kind":"exercise","planned":false,"acquired":false,"shares":34483,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ImmunityBio, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Five percent (5%) of the 172,420 RSUs (rounded down to the nearest whole share) vested on September 9, 2021; five percent (5%) of the RSUs (rounded down to the nearest whole share) vested on December 31, 2022; twenty percent (20%) of the RSUs (rounded down to the nearest whole share) vested on December 31, 2023; twenty percent (20%) of the RSUs (rounded down to the nearest whole share) will vest on December 31, 2024; twenty percent (20%) of the RSUs (rounded down to the nearest whole share) will vest on December 31, 2025; and the remaining RSUs will vest on December 31, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Five percent (5%) of the 172,420 RSUs (rounded down to the nearest whole share) vested on September 9, 2021; five percent (5%) of the RSUs (rounded down to the nearest whole share) vested on December 31, 2022; twenty percent (20%) of the RSUs (rounded down to the nearest whole share) vested on December 31, 2023; twenty percent (20%) of the RSUs (rounded down to the nearest whole share) will vest on December 31, 2024; twenty percent (20%) of the RSUs (rounded down to the nearest whole share) will vest on December 31, 2025; and the remaining RSUs will vest on December 31, 2026."}],"balance_after":120697,"derivative":{"underlying":"Common Stock","underlying_shares":34483},"source":{"system":"sec-edgar","filing":"0001326110-24-000007","document":"wk-form4_1704336033.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611024000007/wk-form4_1704336033.xml","form_type":"4"}},{"id":1691682,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":64915,"kind":"person","name":"Adcock Richard","position":1,"cik":"0001830328","reported_name":"Adcock Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2024-01-04T02:40:45.000Z","date":"2023-12-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":17096,"price":5.02,"value":85821.92,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 31, 2023, the Reporting Person's RSUs vested. The closing price of Immunity Bio, Inc.'s common stock on December 29, 2023 was the settlement price used to calculate the shares withheld."}],"balance_after":202969,"source":{"system":"sec-edgar","filing":"0001326110-24-000007","document":"wk-form4_1704336033.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611024000007/wk-form4_1704336033.xml","form_type":"4"}},{"id":1691681,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":64915,"kind":"person","name":"Adcock Richard","position":1,"cik":"0001830328","reported_name":"Adcock Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2024-01-04T02:40:45.000Z","date":"2023-12-31","kind":"exercise","planned":false,"acquired":true,"shares":34483,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":220065,"source":{"system":"sec-edgar","filing":"0001326110-24-000007","document":"wk-form4_1704336033.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611024000007/wk-form4_1704336033.xml","form_type":"4"}},{"id":2028262,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":64915,"kind":"person","name":"Adcock Richard","position":1,"cik":"0001830328","reported_name":"Adcock Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Restricted Stock Units","published_at":"2023-02-07T23:23:03.000Z","date":"2023-02-05","kind":"exercise","acquired":false,"shares":83333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ImmunityBio, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the Amended and Restated 2015 Equity Incentive Plan) through each applicable vesting date, 83,333 of the shares subject to the RSU award shall vest in equal annual installments on each of the first and second anniversaries of the vesting commencement date and 83,334 of the shares shall vest on the third anniversary of the vesting commencement date, such that all shares shall be fully vested on the third anniversary of the vesting commencement date. The vesting commencement date for this RSU award is February 5, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the Amended and Restated 2015 Equity Incentive Plan) through each applicable vesting date, 83,333 of the shares subject to the RSU award shall vest in equal annual installments on each of the first and second anniversaries of the vesting commencement date and 83,334 of the shares shall vest on the third anniversary of the vesting commencement date, such that all shares shall be fully vested on the third anniversary of the vesting commencement date. The vesting commencement date for this RSU award is February 5, 2021."}],"balance_after":83334,"derivative":{"underlying":"Common Stock","underlying_shares":83333},"source":{"system":"sec-edgar","filing":"0001326110-23-000010","document":"wf-form4_167581216683429.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611023000010/wf-form4_167581216683429.xml","form_type":"4"}},{"id":2028261,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":64915,"kind":"person","name":"Adcock Richard","position":1,"cik":"0001830328","reported_name":"Adcock Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2023-02-07T23:23:03.000Z","date":"2023-02-05","kind":"tax_withholding","acquired":false,"shares":42192,"price":4.33,"value":182691.36,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 5, 2023, the Reporting Person's RSUs vested. The closing price of Immunity Bio, Inc.'s common stock on February 3, 2022 was the settlement price used to calculate the shares withheld."}],"balance_after":185582,"source":{"system":"sec-edgar","filing":"0001326110-23-000010","document":"wf-form4_167581216683429.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611023000010/wf-form4_167581216683429.xml","form_type":"4"}},{"id":2028260,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":64915,"kind":"person","name":"Adcock Richard","position":1,"cik":"0001830328","reported_name":"Adcock Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2023-02-07T23:23:03.000Z","date":"2023-02-05","kind":"exercise","acquired":true,"shares":83333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ImmunityBio, Inc. common stock."}],"balance_after":227774,"source":{"system":"sec-edgar","filing":"0001326110-23-000010","document":"wf-form4_167581216683429.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611023000010/wf-form4_167581216683429.xml","form_type":"4"}},{"id":2066695,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":64915,"kind":"person","name":"Adcock Richard","position":1,"cik":"0001830328","reported_name":"Adcock Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Restricted Stock Units","published_at":"2023-01-05T02:48:54.000Z","date":"2022-12-31","kind":"exercise","acquired":false,"shares":8620,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ImmunityBio, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Five percent (5%) of the 172,420 RSUs (rounded down to the nearest whole share) vested on September 9, 2021; five percent (5%) of the RSUs (rounded down to the nearest whole share) vested on December 31, 2022; twenty percent (20%) of the RSUs (rounded down to the nearest whole share) will vest on December 31, 2023; twenty percent (20%) of the RSUs (rounded down to the nearest whole share) will vest on December 31, 2024; twenty percent (20%) of the RSUs (rounded down to the nearest whole share) will vest on December 31, 2025; and the remaining RSUs will vest on December 31, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Five percent (5%) of the 172,420 RSUs (rounded down to the nearest whole share) vested on September 9, 2021; five percent (5%) of the RSUs (rounded down to the nearest whole share) vested on December 31, 2022; twenty percent (20%) of the RSUs (rounded down to the nearest whole share) will vest on December 31, 2023; twenty percent (20%) of the RSUs (rounded down to the nearest whole share) will vest on December 31, 2024; twenty percent (20%) of the RSUs (rounded down to the nearest whole share) will vest on December 31, 2025; and the remaining RSUs will vest on December 31, 2026."}],"balance_after":155180,"derivative":{"underlying":"Common Stock","underlying_shares":8620},"source":{"system":"sec-edgar","filing":"0001326110-23-000004","document":"wf-form4_167288691221514.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611023000004/wf-form4_167288691221514.xml","form_type":"4"}},{"id":2066694,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":64915,"kind":"person","name":"Adcock Richard","position":1,"cik":"0001830328","reported_name":"Adcock Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2023-01-05T02:48:54.000Z","date":"2022-12-31","kind":"tax_withholding","acquired":false,"shares":4273,"price":5.07,"value":21664.11,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 31, 2022, the Reporting Person's RSUs vested. The closing price of Immunity Bio, Inc.'s common stock on December 30, 2022 was the settlement price used to calculate the shares withheld."}],"balance_after":144441,"source":{"system":"sec-edgar","filing":"0001326110-23-000004","document":"wf-form4_167288691221514.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611023000004/wf-form4_167288691221514.xml","form_type":"4"}},{"id":2066693,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":64915,"kind":"person","name":"Adcock Richard","position":1,"cik":"0001830328","reported_name":"Adcock Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2023-01-05T02:48:54.000Z","date":"2022-12-31","kind":"exercise","acquired":true,"shares":8620,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":148714,"source":{"system":"sec-edgar","filing":"0001326110-23-000004","document":"wf-form4_167288691221514.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611023000004/wf-form4_167288691221514.xml","form_type":"4"}},{"id":2317611,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":64915,"kind":"person","name":"Adcock Richard","position":1,"cik":"0001830328","reported_name":"Adcock Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Stock Option (right to buy)","published_at":"2022-03-26T01:04:23.000Z","date":"2022-03-23","kind":"grant","acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the Issuer's attainment of a financial goal for fiscal year 2022, one-third (1/3rd) of the shares subject to the option shall vest in equal annual installments on each of the first, second and third anniversaries of the vesting commencement date, such that all shares shall be fully vested on the third anniversary of the vesting commencement date, subject to the reporting person's continuing to be a Service Provider (as defined in the Amended and Restated 2015 Equity Incentive Plan) through each applicable vesting date. The vesting commencement date for this option is March 23, 2022."}],"balance_after":350000,"derivative":{"exercise_price":5.83,"expiration_date":"2032-03-23","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0001326110-22-000018","document":"wf-form4_164825664654486.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611022000018/wf-form4_164825664654486.xml","form_type":"4"}},{"id":2317610,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":64915,"kind":"person","name":"Adcock Richard","position":1,"cik":"0001830328","reported_name":"Adcock Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Stock Option (right to buy)","published_at":"2022-03-26T01:04:23.000Z","date":"2022-03-23","kind":"grant","acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the Amended and Restated 2015 Equity Incentive Plan) through each applicable vesting date, one-third (1/3rd) of the shares subject to the option shall vest in equal annual installments on each of the first, second and third anniversaries of the vesting commencement date, such that all shares shall be fully vested on the third anniversary of the vesting commencement date. The vesting commencement date for this option is March 23, 2022."}],"balance_after":350000,"derivative":{"exercise_price":5.83,"expiration_date":"2032-03-23","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0001326110-22-000018","document":"wf-form4_164825664654486.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611022000018/wf-form4_164825664654486.xml","form_type":"4"}},{"id":2408142,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":64915,"kind":"person","name":"Adcock Richard","position":1,"cik":"0001830328","reported_name":"Adcock Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Restricted Stock Units","published_at":"2022-02-09T01:53:35.000Z","date":"2022-02-05","kind":"exercise","acquired":false,"shares":83333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ImmunityBio, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to the Reporting Person's continuing to be a Service Provider (as defined in the Amended and Restated 2015 Equity Incentive Plan) through each applicable vesting date, 83,333 of the shares subject to the RSU award shall vest in equal annual installments on each of the first and second anniversaries of the vesting commencement date and 83,334 of the shares shall vest on the third anniversary of the vesting commencement date, such that all shares shall be fully vested on the third anniversary of the vesting commencement date. The vesting commencement date for this RSU award is February 5, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Subject to the Reporting Person's continuing to be a Service Provider (as defined in the Amended and Restated 2015 Equity Incentive Plan) through each applicable vesting date, 83,333 of the shares subject to the RSU award shall vest in equal annual installments on each of the first and second anniversaries of the vesting commencement date and 83,334 of the shares shall vest on the third anniversary of the vesting commencement date, such that all shares shall be fully vested on the third anniversary of the vesting commencement date. The vesting commencement date for this RSU award is February 5, 2021."}],"balance_after":166667,"derivative":{"underlying":"Common Stock","underlying_shares":83333},"source":{"system":"sec-edgar","filing":"0001326110-22-000006","document":"wf-form4_164437159900979.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611022000006/wf-form4_164437159900979.xml","form_type":"4"}},{"id":2408141,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":64915,"kind":"person","name":"Adcock Richard","position":1,"cik":"0001830328","reported_name":"Adcock Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2022-02-09T01:53:35.000Z","date":"2022-02-05","kind":"tax_withholding","acquired":false,"shares":29415,"price":5.39,"value":158546.85,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 5, 2022, the Reporting Person's RSUs vested. The RSUs were settled on February 7, 2022, the first business day following the vesting date. The closing price of Immunity Bio, Inc.'s common stock on February 4, 2022 was the settlement price used to calculate the shares withheld."}],"balance_after":140094,"source":{"system":"sec-edgar","filing":"0001326110-22-000006","document":"wf-form4_164437159900979.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611022000006/wf-form4_164437159900979.xml","form_type":"4"}},{"id":2408140,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":64915,"kind":"person","name":"Adcock Richard","position":1,"cik":"0001830328","reported_name":"Adcock Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2022-02-09T01:53:35.000Z","date":"2022-02-05","kind":"exercise","acquired":true,"shares":83333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ImmunityBio, Inc. common stock."}],"balance_after":169509,"source":{"system":"sec-edgar","filing":"0001326110-22-000006","document":"wf-form4_164437159900979.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611022000006/wf-form4_164437159900979.xml","form_type":"4"}},{"id":2545390,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":64915,"kind":"person","name":"Adcock Richard","position":1,"cik":"0001830328","reported_name":"Adcock Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2021-10-09T00:31:00.000Z","date":"2021-10-08","kind":"purchase","acquired":true,"shares":1923,"price":8.805,"value":16932.015,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares held by girlfriend living in the same household as the Reporting Person.  The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that such reporting person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":1930,"source":{"system":"sec-edgar","filing":"0001326110-21-000005","document":"wf-form4_163373943704706.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611021000005/wf-form4_163373943704706.xml","form_type":"4"}},{"id":2545389,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":64915,"kind":"person","name":"Adcock Richard","position":1,"cik":"0001830328","reported_name":"Adcock Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2021-10-09T00:31:00.000Z","date":"2021-10-08","kind":"purchase","acquired":true,"shares":7,"price":9,"value":63.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares held by girlfriend living in the same household as the Reporting Person.  The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that such reporting person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":7,"source":{"system":"sec-edgar","filing":"0001326110-21-000005","document":"wf-form4_163373943704706.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611021000005/wf-form4_163373943704706.xml","form_type":"4"}},{"id":2571878,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":64915,"kind":"person","name":"Adcock Richard","position":1,"cik":"0001830328","reported_name":"Adcock Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2021-09-14T00:32:29.000Z","date":"2021-09-09","kind":"exercise","acquired":false,"shares":8620,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ImmunityBio, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Five percent (5%) of the 172,420 RSUs (rounded down to the nearest whole share) will vest on September 9, 2021; five percent (5%) of the RSUs (rounded down to the nearest whole share) will vest on the earlier of (A) December 31, 2022 and (B) the 60th day following approval by the Food and Drug Administration (FDA) of a biologics license application (BLA) or equivalent application for approval of Anktiva for use in the treatment of non-muscle invasive bladder cancer; twenty percent (20%) of the RSUs (rounded down to the nearest whole share) will vest on December 31, 2023; twenty percent (20%) of the RSUs (rounded down to the nearest whole share) will vest on December 31, 2024; twenty percent (20%) of the RSUs (rounded down to the nearest whole share) will vest on December 31, 2025; and the remaining RSUs will vest on December 31, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Five percent (5%) of the 172,420 RSUs (rounded down to the nearest whole share) will vest on September 9, 2021; five percent (5%) of the RSUs (rounded down to the nearest whole share) will vest on the earlier of (A) December 31, 2022 and (B) the 60th day following approval by the Food and Drug Administration (FDA) of a biologics license application (BLA) or equivalent application for approval of Anktiva for use in the treatment of non-muscle invasive bladder cancer; twenty percent (20%) of the RSUs (rounded down to the nearest whole share) will vest on December 31, 2023; twenty percent (20%) of the RSUs (rounded down to the nearest whole share) will vest on December 31, 2024; twenty percent (20%) of the RSUs (rounded down to the nearest whole share) will vest on December 31, 2025; and the remaining RSUs will vest on December 31, 2026."}],"balance_after":163800,"derivative":{"underlying":"Common Stock","underlying_shares":8620},"source":{"system":"sec-edgar","filing":"0001209191-21-055785","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000120919121055785/doc4.xml","form_type":"4"}},{"id":2571877,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":64915,"kind":"person","name":"Adcock Richard","position":1,"cik":"0001830328","reported_name":"Adcock Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-09-14T00:32:29.000Z","date":"2021-09-09","kind":"tax_withholding","acquired":false,"shares":4273,"price":9.95,"value":42516.35,"ownership":{"direct":true},"balance_after":86176,"source":{"system":"sec-edgar","filing":"0001209191-21-055785","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000120919121055785/doc4.xml","form_type":"4"}},{"id":2571876,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":64915,"kind":"person","name":"Adcock Richard","position":1,"cik":"0001830328","reported_name":"Adcock Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-09-14T00:32:29.000Z","date":"2021-09-09","kind":"exercise","acquired":true,"shares":8620,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ImmunityBio, Inc. common stock."}],"balance_after":90449,"source":{"system":"sec-edgar","filing":"0001209191-21-055785","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000120919121055785/doc4.xml","form_type":"4"}},{"id":2749437,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":64915,"kind":"person","name":"Adcock Richard","position":1,"cik":"0001830328","reported_name":"Adcock Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2021-04-15T00:18:42.000Z","date":"2021-03-09","kind":"other","acquired":true,"shares":172420,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ImmunityBio, Inc. common stock."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Upon the terms and subject to the conditions set forth in the Agreement and Plan of Merger, dated as of December 21, 2020, by and among NantKwest. Inc. (\"NantKwest\"), Nectarine Merger Sub, Inc., a wholly owned subsidiary of NantKwest (\"Merger Sub\"), and ImmunityBio, Inc. (\"ImmunityBio\"), Merger Sub merged with and into ImmunityBio, with ImmunityBio surviving as a wholly owned subsidiary of NantKwest and was renamed NantCell, Inc. Following the completion of the merger, NantKwest was renamed ImmunityBio, Inc. In the merger, NantKwest issued to the stockholders of ImmunityBio 0.8190 of a share of its common stock, par value $0.0001 per share, for each outstanding share of ImmunityBio common stock, and the derivative securities of ImmunityBio were also correspondingly converted to derivatives of NantKwest at the same ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Five percent (5%) of the 172,420 RSUs (rounded down to the nearest whole share) will vest on September 9, 2021; five percent (5%) of the RSUs (rounded down to the nearest whole share) will vest on the earlier of (A) December 31, 2022 and (B) the 60th day following approval by the Food and Drug Administration (FDA) of a biologics license application (BLA) or equivalent application for approval of Anktiva for use in the treatment of non-muscle invasive bladder cancer; twenty percent (20%) of the RSUs (rounded down to the nearest whole share) will vest on December 31, 2023; twenty percent (20%) of the RSUs (rounded down to the nearest whole share) will vest on December 31, 2024; twenty percent (20%) of the RSUs (rounded down to the nearest whole share) will vest on December 31, 2025; and the remaining RSUs will vest on December 31, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Five percent (5%) of the 172,420 RSUs (rounded down to the nearest whole share) will vest on September 9, 2021; five percent (5%) of the RSUs (rounded down to the nearest whole share) will vest on the earlier of (A) December 31, 2022 and (B) the 60th day following approval by the Food and Drug Administration (FDA) of a biologics license application (BLA) or equivalent application for approval of Anktiva for use in the treatment of non-muscle invasive bladder cancer; twenty percent (20%) of the RSUs (rounded down to the nearest whole share) will vest on December 31, 2023; twenty percent (20%) of the RSUs (rounded down to the nearest whole share) will vest on December 31, 2024; twenty percent (20%) of the RSUs (rounded down to the nearest whole share) will vest on December 31, 2025; and the remaining RSUs will vest on December 31, 2026."}],"balance_after":172420,"derivative":{"underlying":"Common Stock","underlying_shares":172420},"source":{"system":"sec-edgar","filing":"0001209191-21-026746","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000120919121026746/doc4.xml","form_type":"4"}},{"id":2871601,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":64915,"kind":"person","name":"Adcock Richard","position":1,"cik":"0001830328","reported_name":"Adcock Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2021-02-10T02:47:40.000Z","date":"2021-02-05","kind":"exercise","acquired":false,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of NantKwest, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One hundred percent (100%) of the shares subject to the RSU award shall vest on the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"One hundred percent (100%) of the shares subject to the RSU award shall vest on the date of grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-21-009135","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000120919121009135/doc4.xml","form_type":"4"}},{"id":2871600,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":64915,"kind":"person","name":"Adcock Richard","position":1,"cik":"0001830328","reported_name":"Adcock Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2021-02-10T02:47:40.000Z","date":"2021-02-05","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of NantKwest, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One hundred percent (100%) of the shares subject to the RSU award shall vest on the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"One hundred percent (100%) of the shares subject to the RSU award shall vest on the date of grant."}],"balance_after":150000,"derivative":{"underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-21-009135","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000120919121009135/doc4.xml","form_type":"4"}},{"id":2871599,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":64915,"kind":"person","name":"Adcock Richard","position":1,"cik":"0001830328","reported_name":"Adcock Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2021-02-10T02:47:40.000Z","date":"2021-02-05","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of NantKwest, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the Amended and Restated 2015 Equity Incentive Plan) through each applicable vesting date, 83,333 of the shares subject to the RSU award shall vest in equal annual installments on each of the first and second anniversaries of the vesting commencement date and 83,334 of the shares shall vest on the third anniversary of the vesting commencement date, such that all shares shall be fully vested on the third anniversary of the vesting commencement date. The vesting commencement date for this RSU award is February 5, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the Amended and Restated 2015 Equity Incentive Plan) through each applicable vesting date, 83,333 of the shares subject to the RSU award shall vest in equal annual installments on each of the first and second anniversaries of the vesting commencement date and 83,334 of the shares shall vest on the third anniversary of the vesting commencement date, such that all shares shall be fully vested on the third anniversary of the vesting commencement date. The vesting commencement date for this RSU award is February 5, 2021."}],"balance_after":250000,"derivative":{"underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001209191-21-009135","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000120919121009135/doc4.xml","form_type":"4"}},{"id":2871598,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":64915,"kind":"person","name":"Adcock Richard","position":1,"cik":"0001830328","reported_name":"Adcock Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-02-10T02:47:40.000Z","date":"2021-02-05","kind":"grant","acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the Amended and Restated 2015 Equity Incentive Plan) through each applicable vesting date, one-third (1/3rd) of the shares subject to the option shall vest in equal annual installments on each of the first, second and third anniversaries of the vesting commencement date, such that all shares shall be fully vested on the third anniversary of the vesting commencement date. The vesting commencement date for this option is February 5, 2021."}],"balance_after":750000,"derivative":{"exercise_price":23.72,"expiration_date":"2031-02-05","underlying":"Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001209191-21-009135","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000120919121009135/doc4.xml","form_type":"4"}},{"id":2871597,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":64915,"kind":"person","name":"Adcock Richard","position":1,"cik":"0001830328","reported_name":"Adcock Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-02-10T02:47:40.000Z","date":"2021-02-05","kind":"tax_withholding","acquired":false,"shares":68171,"price":23.72,"value":1617016.12,"ownership":{"direct":true},"balance_after":81829,"source":{"system":"sec-edgar","filing":"0001209191-21-009135","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000120919121009135/doc4.xml","form_type":"4"}},{"id":2871596,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":64915,"kind":"person","name":"Adcock Richard","position":1,"cik":"0001830328","reported_name":"Adcock Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-02-10T02:47:40.000Z","date":"2021-02-05","kind":"exercise","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of NantKwest, Inc. common stock."}],"balance_after":150000,"source":{"system":"sec-edgar","filing":"0001209191-21-009135","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000120919121009135/doc4.xml","form_type":"4"}}]}